A high percentage of serum samples that test reactive by enzyme immunoassay for anti-brucella antibodies are not confirmed by the standard tube agglutination test

Matthew J. Binnicker, Elitza S. Theel, Staci M. Larsen, Robin Patel

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We describe a retrospective analysis of Brucella enzyme immunoassay (EIA) IgM and IgG results compared to those of the standard tube agglutination test (SAT). Among 1,091 samples tested, 104 (9.5%) and 24 (2.2%) sera were positive by IgM and IgG EIA, respectively. Supplemental testing by SAT showed that 82.7% (86/104) of IgM EIA-reactive samples and 54.2% (13/24) of IgG EIA-reactive samples were negative by SAT. Testing all EIA screen-reactive samples by SAT is required when evaluating patients for potential brucellosis. Due to the limitations of serology, culture remains the gold standard for detecting Brucella infection.

Original languageEnglish (US)
Pages (from-to)1332-1334
Number of pages3
JournalClinical and Vaccine Immunology
Volume19
Issue number8
DOIs
StatePublished - Aug 2012

Fingerprint

Agglutination Tests
Brucella
Immunoenzyme Techniques
Anti-Idiotypic Antibodies
Antibodies
Immunoglobulin M
Enzymes
Serum
Immunoglobulin G
Brucellosis
Testing
Serology
Infection

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)

Cite this

A high percentage of serum samples that test reactive by enzyme immunoassay for anti-brucella antibodies are not confirmed by the standard tube agglutination test. / Binnicker, Matthew J.; Theel, Elitza S.; Larsen, Staci M.; Patel, Robin.

In: Clinical and Vaccine Immunology, Vol. 19, No. 8, 08.2012, p. 1332-1334.

Research output: Contribution to journalArticle

@article{21afb872f531453bb96cfc358f544efe,
title = "A high percentage of serum samples that test reactive by enzyme immunoassay for anti-brucella antibodies are not confirmed by the standard tube agglutination test",
abstract = "We describe a retrospective analysis of Brucella enzyme immunoassay (EIA) IgM and IgG results compared to those of the standard tube agglutination test (SAT). Among 1,091 samples tested, 104 (9.5{\%}) and 24 (2.2{\%}) sera were positive by IgM and IgG EIA, respectively. Supplemental testing by SAT showed that 82.7{\%} (86/104) of IgM EIA-reactive samples and 54.2{\%} (13/24) of IgG EIA-reactive samples were negative by SAT. Testing all EIA screen-reactive samples by SAT is required when evaluating patients for potential brucellosis. Due to the limitations of serology, culture remains the gold standard for detecting Brucella infection.",
author = "Binnicker, {Matthew J.} and Theel, {Elitza S.} and Larsen, {Staci M.} and Robin Patel",
year = "2012",
month = "8",
doi = "10.1128/CVI.00197-12",
language = "English (US)",
volume = "19",
pages = "1332--1334",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - A high percentage of serum samples that test reactive by enzyme immunoassay for anti-brucella antibodies are not confirmed by the standard tube agglutination test

AU - Binnicker, Matthew J.

AU - Theel, Elitza S.

AU - Larsen, Staci M.

AU - Patel, Robin

PY - 2012/8

Y1 - 2012/8

N2 - We describe a retrospective analysis of Brucella enzyme immunoassay (EIA) IgM and IgG results compared to those of the standard tube agglutination test (SAT). Among 1,091 samples tested, 104 (9.5%) and 24 (2.2%) sera were positive by IgM and IgG EIA, respectively. Supplemental testing by SAT showed that 82.7% (86/104) of IgM EIA-reactive samples and 54.2% (13/24) of IgG EIA-reactive samples were negative by SAT. Testing all EIA screen-reactive samples by SAT is required when evaluating patients for potential brucellosis. Due to the limitations of serology, culture remains the gold standard for detecting Brucella infection.

AB - We describe a retrospective analysis of Brucella enzyme immunoassay (EIA) IgM and IgG results compared to those of the standard tube agglutination test (SAT). Among 1,091 samples tested, 104 (9.5%) and 24 (2.2%) sera were positive by IgM and IgG EIA, respectively. Supplemental testing by SAT showed that 82.7% (86/104) of IgM EIA-reactive samples and 54.2% (13/24) of IgG EIA-reactive samples were negative by SAT. Testing all EIA screen-reactive samples by SAT is required when evaluating patients for potential brucellosis. Due to the limitations of serology, culture remains the gold standard for detecting Brucella infection.

UR - http://www.scopus.com/inward/record.url?scp=84864567795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864567795&partnerID=8YFLogxK

U2 - 10.1128/CVI.00197-12

DO - 10.1128/CVI.00197-12

M3 - Article

VL - 19

SP - 1332

EP - 1334

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 8

ER -